Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        PRV-211 by Privo Technologies for Lip Cancer: Likelihood of Approval
PRV-211 is under clinical development by Privo Technologies and currently in Phase II for Lip Cancer. According to GlobalData, Phase...
                                                Data Insights
                                                
                                        PRV-211 by Privo Technologies for Oral Cavity (Mouth) Cancer: Likelihood of Approval
PRV-211 is under clinical development by Privo Technologies and currently in Phase II for Oral Cavity (Mouth) Cancer. According to...
